ARRB1 and neoplasm: Nevertheless, the results obtained in poorly differentiated tumours contrasted with the data obtained in the in-house TMA (4/9 SCC samples were beta-arrestin-1-2- and beta-arrestin-1-positive and one ADC sample was beta-arrestin-1-negative) (Supplementary Table 6).